Page 8 - Return Ready News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Ladies and gentlemen, good morning, and welcome to the CVS Health fourth-quarter and full-year 2020 earnings conference call. [Operator instructions] I would now like to turn the call over to Valerie Haertel, senior vice president of investor relations for CVS Health. Please go ahead. Valerie Haertel -- Senior Vice President of Investor Relations Thank you, and good morning, everyone. Welcome to the CVS Health fourth-quarter and full-year 2020 earnings call. I'm Valerie Haertel, senior vice president of investor relations for CVS Health. I am joined this morning by Karen Lynch, pres...

The National Association of Counties (NACo) and CVS Health are proud to introduce a new cutting edge COVID-19 testing solution for local government employers and employees called Return Ready. | Health

Pfizer, BioNTech , and Moderna (NASDAQ:MRNA) have seen their shares rise over the past few months because of their work to develop vaccines against COVID-19. Moderna, which started off the year with a share price of $19.50 has seen its stock climb more than 608% year to date to $138. CVS Health (NYSE:CVS) is probably not the first company you think of when you think of a "coronavirus" stock, but it will be one in 2021, and unlike Moderna, it's long been profitable. Image source: Getty Images. What's coming for CVS? The pharmacy and health benefits provider will serve as a place where consum...